Patterns of Care and Treatment outcomes of High-Grade Glioma Patients at four Ethiopian Teaching Hospitals

No Thumbnail Available

Date

2024-10-10

Journal Title

Journal ISSN

Volume Title

Publisher

Addis Ababa University

Abstract

Background: High-grade gliomas are the most prevalent type of malignant brain tumor in adults. The most prevalent cancers of the primary central nervous system (CNS) in adults are malignant astrocytoma, which includes anaplastic astrocytoma (WHO grade III), Malignant Astrocytoma (IDH mutant) or glioblastoma - IDH wild-type (WHO grade IV), and gliosarcoma (WHO grade IV). They are the second leading cause of cancer-related death in the young adult population and are linked with significant morbidity. Despite extensive study, people with malignant gliomas continue to have a dismal prognosis. The goal of this study is to assess the care and treatment outcomes for people with this condition. Objectives: To assess the pattern of care, treatment outcome and its associated factors in the treatment of High grade Glioma patients found at Tikur Anbessa Specialized Hospital and affiliate neurosurgical Hospitals in Addis Ababa, Ethiopia, from September 1, 2023- September 1, 2024 Methods: Prospective cohort study collected data on pattern of care, treatment outcome and associated factors High grade Glioma patients found at TikurAnbessa Specialized Hospital and affiliate neurosurgical Hospitals. Data was collected by trained senior neurosurgical residents. Data collected was analyzed using SPSS. Frequency distribution was used to describe the characteristics of the study participants. Data analysis included chi-squared tests and survival analysis tests to assess the treatment outcomes. Variables with p <0.05 were considered as significant. Result: There were 40 patients with confirmed HGG who participated in this study. The median age at diagnosis was 47 years. Headache is the commonest presenting symptom in this study (97.5%) followed by seizure (52.5%) and weakness (50%). The pre-operative tumor volume among the study participants ranged between 3.9-168 cm3. The mean preoperative tumor volume was 80.38 cm3. Out of the 40 patients 22 of them had ≥ 97% extent of resection. In this study 17.5% of the patients diagnosed with HGG died post-surgery from which 71.4% had WHO grade 4 tumor. The median survival time for patients with HGG post-surgery was 11.3 months (95% CI: 6.2-17months). There was significant association in patients with higher KPS (≥ 70) value and their survival outcome. (χ2= 10.19 P=0.006). Patients with pre-operative GCS (≤ 14) seem to have significant association on survival outcome compared with patients having GCS of 15. (χ2= 12.9 P=0.005). Those patients who received post-operative adjuvant therapy have better survival outcome than those patients with no adjuvant therapy. (χ2= 6.716) P=0.035). Conclusion: High-grade glioma (HGG) represents the most aggressive primary brain tumor, and its incidence continues to rise globally. Higher KPS, pre-operative GCS of 15 and those patients receiving post-OP adjuvant therapy had significant favorable association with survival. It is critical to continue advocating and engaging with the government and stakeholders about the importance of enhancing access to radiotherapy and chemotherapy. Key Words: High grade glioma, brain tumor, GBM, glioma,

Description

Keywords

High grade glioma brain tumor GBM glioma

Citation

Collections